Marinus Pharmaceuticals (NASDAQ:MRNS) Downgraded by StockNews.com to Sell : vimarsana.com

StockNews.com downgraded shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Wednesday. Several other brokerages also recently weighed in on MRNS. Truist Financial cut their price target on Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating on […]

Related Keywords

Canada , , Life Insurance Co , Marinus Pharmaceuticals Stock Performance , Marinus Pharmaceuticals Inc , Royal Bank , News Ratings For Marinus Pharmaceuticals Daily , Tower Research Capital , Marinus Pharmaceuticals , Charles Schwab Investment Management Inc , Nuveen Asset Management , Deutsche Bank , Analyst Recommendations For Marinus Pharmaceuticals , Free Report , Moderate Buy , Get Free Report , Asset Management , Schwab Investment Management , Research Capital , Marinus Pharmaceuticals Daily ,